Vaerloese, Denmark

Susanne Hostrup

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Susanne Hostrup: Innovator in Diabetes Treatment

Introduction

Susanne Hostrup is a prominent inventor based in Vaerloese, Denmark. She has made significant contributions to the field of diabetes treatment through her innovative research and development of pharmaceutical compounds. With a total of five patents to her name, Hostrup is recognized for her work in creating novel therapeutic solutions.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "Bifunctional compounds comprising insulin peptides and EGF(A) peptides." This invention relates to novel covalently linked bi-functional fusion proteins that include insulin and EGF(A) analogues or derivatives. The pharmaceutical applications of this invention focus on treating or preventing medical conditions associated with diabetes and dyslipidaemia. The second patent, "Insulin derivatives and the medical uses hereof," pertains to acylated derivatives of human insulin analogues. This invention also provides pharmaceutical compositions for the treatment or prevention of diabetes-related medical conditions.

Career Highlights

Susanne Hostrup is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work at Novo Nordisk has allowed her to focus on developing innovative solutions that address the challenges faced by individuals with diabetes. Hostrup's dedication to her research has positioned her as a key figure in the pharmaceutical industry.

Collaborations

Throughout her career, Hostrup has collaborated with esteemed colleagues, including Mathias Norrman and Peter Madsen. These collaborations have further enhanced her research and contributed to the advancement of diabetes treatment.

Conclusion

Susanne Hostrup's contributions to the field of diabetes treatment through her innovative patents and work at Novo Nordisk highlight her importance as an inventor. Her dedication to improving medical solutions for diabetes continues to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…